Medgenics gets patent for EPO pump; Alexza's Adusave aerosol loxapine coming closer to market;

> Adusave, aerosol-delivered loxapine using Alexza Pharmaceuticals' ($ALXA) Staccato delivery system, could gain approval in the U.S. and Europe next month. Article | Press release

> Medgenics' ($MDGN) Epodure Biopump technology has been granted a U.S. patent for the delivery of erythropoietin (EPO). Article

> Impax Laboratories and Perrigo are working together to develop, manufacture, and commercialize a topical generic drug. Article

> Sanovas has received a patent for its nested balloon catheter for localized drug delivery, part of its Vas Zeppelin Smart Catheter technology portfolio. Article

> Alliqua is looking into using its proprietary transdermal delivery platform in the cosmeceutical industry. Press release

> Italian researchers are developing niosomes to deliver anti-inflammatory drugs. Article

And Finally… Whipworm infection could alleviate autism--a novel drug delivery device? Article